SMYD3 Rabbit Polyclonal Antibody
Catalog #:EAB13474
Host / Isotype Clonality Applications MW (kDa) Reactivity
Rabbit IgG Polyclonal WB, ELISA 49 Human, Mouse
Applications Dilutions
The application notes include recommended starting dilutions;optimal dilutions/concentrations should be detemined by the end user.
WB=1:500-2000
Application Key

WB-Western Blot IP-Immunoprecipitation IHC-Immunohistochemistry IHC-P-Immunohistochemistry-Paraffin
IF
-Immunofluorescence ICC-Immunocytochemistry FC-Flow Cytometry

Reactivity Key

H-Human M-Mouse R-Rat Mk-Monkey B-Bovine Pg-Pig Hm-Hamster Dg-Dog C-Chicken X-Xenopus Z-Zebrafish
Hr
-Horse All-All Species Expected

Product Information
Conjugate Unconjugate
Specificity SMYD3 Rabbit Polyclonal Antibody detects endogenous levels of SMYD3 protein.
Purification Affinity purification
Concentration 1mg/ml
Format Liquid
Formulation In PBS, pH 7.4, containing 0.02% sodium azide,0.5% BSA and 50% glycerol.
Shipping Gel Pack
Storage Store at -20°C least 1 year from the date of shipment. avoid repeated freeze/thaw cycles. Aliquots may be stored at +4°C for 1-2 weeks.
UniProt ID

Q9H7B4

Entrez Gene ID

64754

Product Description

SMYD3(SET and MYND domain-containing 3) is a histone methyltransferase which functions in RNA polymerase II complexes by an interaction with a specific RNA helicase. SMYD3 is responsible for the methylation of Lys-4 on Histone H3, a modification that serves as a specific marker for epigenetic transcriptional activation, thereby influencing gene expression patterns essential for cellular function and development. SMYD3 features an N-terminal MYND-type zinc finger domain followed by a SET domain, which is integral to methyltransferase activity. Additionally, the presence of heat shock protein HSP 90A significantly enhances SMYD3 methyltransferase activity, highlighting the importance of protein interactions in regulating function. SMYD3 is predominantly expressed in testis and skeletal muscle tissues and is found to be over-expressed in a majority of colorectal carcinomas, hepatocellular carcinomas, and breast carcinomas, making SMYD3 a potential target for therapeutic intervention in cancer treatment. 

Product Image Gallery
For Research Use Only, Not For Diagnostic Or Therapeutic Procedures.
EbioCell Lifescineces, Inc.   Order:400-117-0038   order@ebiocell.com   Support: tech@ebiocell.com   Web:ebiocell.com